ChemAbout
© 2026 ChemAbout
Insights|Privacy Policy|Terms of Service|[email protected]
Home/Compounds/API/Darunavir
C27H37N3O7S
547.7 g/mol
APIWarning

Darunavir

CAS206361-99-1
Category
API
Compound Class
Other
Primary Use
Pharmaceutical Raw Material

Darunavir is a second-generation HIV protease inhibitor designed to maintain activity against many resistant viral strains. It is a sulfonamide compound with a complex polycyclic structure, used in pharmaceutical manufacturing as an active pharmaceutical ingredient.

HIV protease inhibitorantiviral active pharmaceutical ingredient

Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.

Sourcing or supplying this compound?

List your inventory or post a purchase request

CAS 206361-99-1

List This Product
Sign in to publish supply information
Request This Product
Submit a request without registering

Related Compounds

StrongSame Parent

Darunavir ethanolate

CAS635728-49-3

pharmaceutical raw material

StrongSame Parent

Darunavir propylene glycolate

CAS1447721-06-3

pharmaceutical intermediate

SimilarStructure SimilarSimilarity 0.84

Carbamic acid, N-[(1S,2R)-3-[[[4-(acetylamino)phenyl]sulfonyl](2-methylpropyl)amino]-2-hydroxy-1-(phenylmethyl)propyl]-, (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl ester

CAS1546919-11-2

pharmaceutical raw material

SimilarStructure SimilarSimilarity 0.75

N-{4-[{(2R,3S)-3-[({[(3R,3aS,6aR)-Hexahydrofuro[2,3-b]furan-3-yl]oxy}carbonyl)amino]-2-hydroxy-4-phenylbutyl}(2-methylpropyl)sulfamoyl]phenyl}-beta-D-glucopyranuronosylamine

CAS1159613-25-8

pharmaceutical raw material

ReferenceSame Category

Vincristine sulfate

CAS2068-78-2

pharmaceutical raw material

ReferenceSame Category

Bamifylline hydrochloride

CAS20684-06-4

pharmaceutical raw material

ReferenceSame Category

Nefextinib

CAS2070931-57-4

pharmaceutical raw material

ReferenceSame Category

Methyl (S)-phenyl[(R)-piperidin-2-yl]acetate

CAS20748-12-3

pharmaceutical raw material

Safety Reference

Harmful
Harmful
Warning
H315Causes skin irritation
H317May cause an allergic skin reaction
H319Causes serious eye irritation
H335May cause respiratory irritation
Identifiers
IUPAC Name

[(3aS,4R,6aR)-2,3,3a,4,5,6a-hexahydrofuro[2,3-b]furan-4-yl] N-[(2S,3R)-4-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]carbamate

InChIKey

CJBJHOAVZSMMDJ-HEXNFIEUSA-N

SMILES

CC(C)CN(C[C@H]([C@H](CC1=CC=CC=C1)NC(=O)O[C@H]2CO[C@@H]3[C@H]2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N

Synonyms (68)
  • DRV
  • Darunavir (USAN/INN)
  • Darunavirum [INN-Latin]
  • 114, TMC
  • 2f80
  • 2f81
  • 2f8g
  • 2hs1
  • 2hs2
  • 2idw
  • 2ien
  • 3bvb
  • 3cyw
  • 3d1z
  • 3d20
  • 3ekt
  • 3ggu
  • 3lzs
  • 3lzu
  • 3lzv
  • 3ogp
  • 3pwm
  • 3qoz
  • 3s53
  • 3s54
  • 3so9
  • 3t3c
  • 3tkw
  • 3ttp
  • 3u7s
  • 4hla
  • 4ll3
  • DARUNAVIR [MART.]
  • DRV & AAG
  • DRV & HSA
  • Darunavir
  • Darunavir (DRV)
  • Darunavir, >=98% (HPLC)
  • Darunavirum
  • Derunavir
  • Ethanolate, Darunavir
  • Prezista
  • Prezista Naive
  • Prezista(TM)